FOTON marks its return to the Australian passenger vehicle market with the arrival of the all-new TUNLAND utes. Sitting ...

The Pensacola News Journal is working with high schools in Escambia and Santa Rosa County to put their top students in the ...

Savvas Learning Company, a next-generation learning solutions leader, is excited to announce that the New Mexico Public Education Department (NMPED) has approved the full suite of Savvas K-12 math ...

An AT&T 5G connectivity deal with Toyota Motor North America turned the spotlight on the US connected vehicle sector at a ...

Nuveen Preferred & Income Opportunities Fund (JPC) offers a 9.78% yield, outperforming preferred stock indices and peer funds ...

Grasping the real worth of gold starts with understanding what 'gold carat' means – a measure that reveals how much pure gold lies beneath its polished surface. This proportion of gold blended with ...

Retail, hospitality and healthcare have long treated employee benefits as a luxury they can't afford. But Gethin Nadin, Chief Innovation Officer at Benifex, argues that the data tells a different ...

Mark McCourt told prospective customer he would throw in 10 pipe bombs to seal €75,000 cash deal to supply guns and ammo ...

Karyopharm Therapeutics Inc. , a commercial-stage pharmaceutical company pioneering novel cancer therapies, today reported financial results for the third quarter ended September 30, 2025 and ...

Odyssey Math Tuition launches standalone e-learning courses in September 2025, offering 24/7 access to video lessons, worksheets, quizzes, and progress tracking via proprietary curriculum, supporting ...

- Duchenne (SGT-003): 23 participants have been dosed in the INSPIRE DUCHENNE trial as of October 31, 2025; Solid expects to have dosed 30 participants in total by early 2026, then plans to meet with ...

Developed by Ascentage Pharma, olverembatinib is the first China-approved third-generation BCR-ABL inhibitor, currently being jointly commercialized in China by Ascentage Pharma and Innovent Biologics ...